Evidence map›Paper›PMID 21212274›Full record

ArticleThe Journal of biological chemistry2011

TAp73 induction by nitric oxide: regulation by checkpoint kinase 1 (CHK1) and protection against apoptosis.

Ali Tebbi, Olivier Guittet, Marie-Hélène Cottet, Marie-Françoise Vesin, Michel Lepoivre

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Ali TebbiFrom the Université Paris-Sud, Institute of Molecular and Cellular Biochemistry and Biophysics, UMR 8619, F-91405 Orsay, France,; CNRS, F-91405 Orsay, France, and; the Division of Endocrinology, Diabetes, and Metabolism, Department of Molecular Medicine, University of Utah School of Medicine, Salt Lake City, Utah 84112.
Olivier GuittetFrom the Université Paris-Sud, Institute of Molecular and Cellular Biochemistry and Biophysics, UMR 8619, F-91405 Orsay, France,; CNRS, F-91405 Orsay, France, and.
Marie-Hélène CottetFrom the Université Paris-Sud, Institute of Molecular and Cellular Biochemistry and Biophysics, UMR 8619, F-91405 Orsay, France,; CNRS, F-91405 Orsay, France, and.
Marie-Françoise VesinFrom the Université Paris-Sud, Institute of Molecular and Cellular Biochemistry and Biophysics, UMR 8619, F-91405 Orsay, France,; CNRS, F-91405 Orsay, France, and.
Michel LepoivreFrom the Université Paris-Sud, Institute of Molecular and Cellular Biochemistry and Biophysics, UMR 8619, F-91405 Orsay, France,; CNRS, F-91405 Orsay, France, and. Electronic address: michel.lepoivre@u-psud.fr.
Centre National de la Recherche Scientifique · FRUniversité Paris-Sud · FRUniversity of Utah · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nitric oxide (NO) is a potent activator of the p53 tumor suppressor protein, thereby inducing cell cycle arrest and apoptosis. However, little is known about the regulation of the two other p53-family members, p63 and p73, by nitrogen oxides. We report here an up-regulation of p73 by NO in p53-null K-562 leukemia cells. Chemical NO prodrugs or macrophage iNOS activity induced an accumulation of the TAp73α isoform in these cells, whereas macrophages from iNOS(-/-) mice did not. NO also up-regulated TAp73 mRNA expression, suggesting a transcriptional regulation. The checkpoint kinases Chk1 and Chk2 can regulate TAp73 induction after DNA damage. We show that these kinases were rapidly phosphorylated upon NO treatment. Genetic silencing or pharmacological inhibition of Chk1 impaired NO-mediated accumulation of TAp73α. Because NO is known to block DNA synthesis through ribonucleotide reductase inhibition, the up-regulation of TAp73α might be caused by DNA damage induced by an arrest of DNA replication forks. In support of this hypothesis, DNA replication inhibitors such as hydroxyurea and aphidicolin similarly enhanced TAp73α expression and Chk1 phosphorylation. Moreover, inhibition of Chk1 also prevented TAp73α accumulation in response to replication inhibitors. The knockdown of TAp73 with siRNA sensitized K-562 cells to apoptosis induced by a nitrosative (NO) or oxidative (H(2)O(2)) injury. Therefore, TAp73α has an unusual cytoprotective role in K-562 cells, contrasting with its pro-apoptotic functions in many other cell models. In conclusion, NO up-regulates several p53 family members displaying pro- and anti-apoptotic effects, suggesting a complex network of interactions and cross-regulations between NO production and p53-related proteins.

Indexed as

AnimalsAntineoplastic AgentsApoptosisCheckpoint Kinase 1DNADNA-Binding ProteinsDNA DamageDNA ReplicationGene Knockdown TechniquesHumansHydroxyureaK562 CellsMacrophages, PeritonealMiceNitric OxideNuclear ProteinsAntineoplastic AgentsCheckpoint Kinase 1CHEK1 protein, humanChek1 protein, mouseDNADNA-Binding ProteinsHydroxyureaNitric OxideNuclear ProteinsProtein KinasesTP73 protein, humanTrp73 protein, mouseTumor Protein p73Tumor Suppressor Proteins

Identifiers

PMID21212274
PMCPMC3048674
OpenAlexW2054104078

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.